FRAILTY AND MORTALITY ASSOCIATION IN PATIENTS WITH COVID-19 : A SYSTEMATIC REVIEW

Authors

  • Yenny Frida Setiawan Faculty of Medicine, Maranatha Christian University

DOI:

https://doi.org/10.53555/nnmhs.v8i11.1427

Keywords:

Covid-19, Frailty, Inflammation, Mortality

Abstract

When a person's physiological reserve is low, they are more susceptible to the negative effects of stress, which can lead to poor health outcomes. This condition is known as frailty. This condition is linked to a number of chronic conditions, many of which are risk factors for the outcomes of SARS-COV-2 infections in elderly patients. This review aims to describe frailty as a physiological vulnerability agent during the Covid-19 pandemic in elderly patients. It will do so by providing a summary of the direct and indirect effects caused by the SARS-COV-2 infection, as well as its prognosis in frail individuals, as well as the interventions and recommendations that can be used to reduce the effects of these infections. However, other scales have also associated frailty with longer hospital stays and more severe forms of the disease. Cohort studies have shown that patients with a Clinical Frailty Scale that is higher than five have a higher risk of mortality and use of mechanical ventilation after Covid-19. In addition, the pandemic's indirect effects have a negative impact on the health status of people who are older in age. As a result of the aforementioned, a holistic intervention is proposed. This intervention is based on a comprehensive geriatric assessment for frail patients and places an emphasis on physical activity and nutritional recommendations. If successful, this intervention could serve as a potential preventive intervention in viral infections caused by Covid-19. One of the primary contributors to a precarious state of life as a result of the gradual loss of physiological functions and a key factor in the development of pathological aging is simply getting older. In this particular study, the overall mortality rate for patients was found to be 38.3% on average.

References

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). Februari 2020;395(10223):497–506.

Yang Y, Du L. SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies. Signal Transduct Target Ther. Februari 2021;6(1):95.

Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B. Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis. Intervirology. 2021;64(1):36–47.

Trecarichi EM, Mazziteli M, Serapide F, et al. Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility. Nature. 2020;10.

Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients. Am J Roentgenol. Juli 2020;215(1):87–93.

Dent E, Martin FC, Bergman H, Woo J, Romero-Ortuno R, Walston JD. Management of frailty: opportunities, challenges, and future directions. Lancet. 2019;394(10206):1376–86.

Payne M, Morley JE. Editorial: Dysphagia, Dementia and Frailty. Vol. 22, The journal of nutrition, health & aging. France; 2018. hal. 562–5.

Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–62.

O’Caoimh R, Galluzzo L, Rodríguez-Laso Á, Van der Heyden J, Ranhoff AH, Lamprini-Koula M, et al. Prevalence of frailty at population level in European ADVANTAGE Joint Action Member States: a systematic review and meta-analysis. Ann Ist Super Sanita. 2018;54(3):226–38.

Vetrano DL, Palmer K, Marengoni A, Marzetti E, Lattanzio F, Roller-Wirnsberger R, et al. Frailty and multimorbidity: a systematic review and meta-analysis. Journals Gerontol Ser A. 2019;74(5):659–66.

Vetrano DL, Palmer KM, Galluzo L, et al. Hypertension and frailty: a systematic review and meta-analysis. Geriatr Med. 2018;8(12):34–9.

Woolford SJ, D’Angelo S, Curtis EM, Parsons CM, Ward KA, Dennison EM, et al. COVID-19 and associations with frailty and multimorbidity: a prospective analysis of UK Biobank participants. Aging Clin Exp Res. September 2020;32(9):1897–905.

De Smet R, Mellaerts B, Vandewinckele H, Lybeert P, Frans E, Ombelet S, et al. Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study. J Am Med Dir Assoc. Juli 2020;21(7):928-932.e1.

Hewitt J, Carter B, Vilches-Moraga A, Quinn TJ, Braude P, Verduri A, et al. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Heal. Agustus 2020;5(8):e444–51.

Owen RK, Conroy SP, Taub N, Jones W, Bryden D, Pareek M, et al. Comparing associations between frailty and mortality in hospitalised older adults with or without COVID-19 infection: a retrospective observational study using electronic health records. Age Ageing. Februari 2021;50(2):307–16.

Marengoni A, Zucchelli A, Grande G, Fratiglioni L, Rizzuto D. The impact of delirium on outcomes for older adults hospitalised with COVID-19. Age Ageing. Oktober 2020;49(6):923–6.

Aw D, Woodrow L, Ogliari G, Harwood R. Association of frailty with mortality in older inpatients with Covid-19: a cohort study. Age Ageing. Oktober 2020;49(6):915–22.

Rawle MJ, Bertfield DL, Brill SE. Atypical presentations of COVID-19 in care home residents presenting to secondary care: A UK single centre study. Aging Med (milt. Desember 2020;3(4):237–44.

Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, et al. Frailty consensus: a call to action. J Am Med Dir Assoc. Juni 2013;14(6):392–7.

Hanlon P, Nicholl BI, Jani BD, Lee D, McQueenie R, Mair FS. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493?737 UK Biobank participants. Lancet Public Heal. Juli 2018;3(7):e323–32.

Smart R, Carter B, McGovern J, Luckman S, Connelly A, Hewitt J, et al. Frailty Exists in Younger Adults Admitted as Surgical Emergency Leading to Adverse Outcomes. J frailty aging. 2017;6(4):219–23.

Gilbert T, Neuburger J, Kraindler J, Keeble E, Smith P, Ariti C, et al. Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study. Lancet (London, England). Mei 2018;391(10132):1775–82.

Hollinghurst J, Fry R, Akbari A, Clegg A, Lyons RA, Watkins A, et al. External validation of the electronic Frailty Index using the population of Wales within the Secure Anonymised Information Linkage Databank. Age Ageing. November 2019;48(6):922–6.

Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). Maret 2020;395(10229):1054–62.

Bellelli G, Rebora P, Valsecchi MG, Bonfanti P, Citerio G. Frailty index predicts poor outcome in COVID-19 patients. Vol. 46, Intensive care medicine. 2020. hal. 1634–6.

Huang C; Wang Y; Li X; et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10334):497–506.

Yang W, Sirajuddin A, Zhang X, Liu G, Teng Z, Zhao S, et al. The role of imaging in 2019 novel coronavirus pneumonia (COVID-19). Vol. 30, European Radiology. Springer Science and Business Media Deutschland GmbH; 2020. hal. 4874–82.

Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. April 2020;10(2):102–8.

McElvaney OJ, McEvoy NL, McElvaney OF, Carroll TP, Murphy MP, Dunlea DM, et al. Characterization of the Inflammatory Response to Severe COVID-19 Illness. Am J Respir Crit Care Med. September 2020;202(6):812–21.

Yang Y, Luo K, Jiang Y, Yu Q, Huang X, Wang J, et al. The Impact of Frailty on COVID-19 Outcomes: A Systematic Review and Meta-analysis of 16 Cohort Studies. J Nutr Health Aging. 2021;25(5):702–9.

Yoelekar M, Sukumaran S. Frailty Syndrome: A Review. J Assoc Physicians India. 2014;62(7):18–23.

Hussien H, Nastasa A, Apetrii M, Nistor I, Petrovic M, Covic A. Different aspects of frailty and COVID-19: points to consider in the current pandemic and future ones. BMC Geriatr [Internet]. 2021;21(1):389. Tersedia pada: https://doi.org/10.1186/s12877-021-02316-5

Pizano-Escalante MG, Anaya-Esparza LM, Nuño K, Rodríguez-Romero J de J, Gonzalez-Torres S, López-de la Mora DA, et al. Direct and Indirect Effects of COVID-19 in Frail Elderly: Interventions and Recommendations. J Pers Med. Oktober 2021;11(10).

Downloads

Published

2022-11-22

How to Cite

Frida Setiawan, Y. . (2022). FRAILTY AND MORTALITY ASSOCIATION IN PATIENTS WITH COVID-19 : A SYSTEMATIC REVIEW. Journal of Advanced Research in Medical and Health Science (ISSN 2208-2425), 8(11), 1-7. https://doi.org/10.53555/nnmhs.v8i11.1427